|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Making Middleboxes Someone Else's Problem: Network Processing as a Cloud Service
If you have a question about this talk, please contact Eiko Yoneki.
Modern enterprises almost ubiquitously deploy middlebox processing services to improve security and performance in their networks. Despite this, today’s middlebox infrastructure is expensive, complex to manage, and creates new failure modes for the networks that use them. Given the promise of cloud computing to decrease costs, ease management, and provide elasticity and fault tolerance, middlebox processing can beneﬁt from outsourcing the cloud. Arriving at a feasible implementation, however, is challenging due to the need to achieve functional equivalence with traditional middlebox deployments without sacriﬁcing performance or increasing network complexity.
In this talk, I will present APLOMB , a practical service for outsourcing enterprise middlebox processing to the cloud. APLOMB ’s motivation and design are data-driven, guided by a survey of 57 enterprise networks, the ﬁrst large-scale academic study of middlebox deployment. Our analysis shows that APLOMB solves real problems faced by network administrators, can outsource over 90% of middlebox hardware in a typical large enterprise network, and, in a case study of a real enterprise, imposes an average latency penalty of 1.1ms and median bandwidth inﬂation of 3.8%.
This talk is part of the Computer Laboratory Systems Research Group Seminar series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsResearch Office Linked Events Audio and Music Processing (AMP) Reading Group Computer Laboratory Programming Research Group Seminar
Other talksThe regulation of gene expression in the context of chromatin In Situ Hybridisation Symposium 2013 CCE Seminar - Title to be confirmed Textures and Topology in Liquid Crystals The organelles and traffic machinery of the late endocytic pathway Risk and uncertainty in radiotherapy. Why I am the weakest link?